Influenza (Common Cold)

INFLUENZA
Kuldeep Vyas M.Sc. CHN

INTRODUCTION
Influenza, commonly referred to as the flu, is
viruses of the family Ortho-myxoviridae
influenza viruses),
an infectious viral disease caused by RNA
(the
that
affects birds and mammals.
Common symptoms are chills, fever, sore
throat, muscle pains, severe headache, coughing,
fatigue and general discomfort.
Although confused with other influenza-like
illnesses, especially the common cold, influenza is
a more severe disease .
2-7-2020 Kuldeep Vyas M.Sc. CHN 2

DEFINITION
WHO : Influenza is a viral infection that
affects mainly the nose, throat, bronchi
and, occasionally, lungs. Infection
usually lasts for about a week, and is
characterized by sudden onset of high
fever, aching muscles, headache and
severe malaise, non-productive cough,
sore throat and rhinitis.

HISTORY
Influenza can be traced as far back as 400 BC
In Hippocrates’ Of the Epidemics, he describes a cough
outbreak that occurred in 412 BC in modern-day Turkey at the turn of
the autumn season
17th century:-
• Between 1781-1782, an influenza epidemic infected 2/3 of Rome’s
population and ¾ of Britain’s population. Later, disease spread to
North America, West Indies, and South America. Spread of pandemic
culminated in New England, New York, and Nova Scotia in 1789.
• 1781 marked the beginning of the of influenza epidemics and
pandemics

American Red Cross nurses keep the flu patients in
temporary wards set up inside the Oakland municipal
Auditorium.

EPIDEMILOGICAL
DETERMINANTS

AGENT
 Influenza viruses are classified within the
family of Ortho-myxoviridae.
 There are three viral sub–types, namely
influenza type A, type B and type C.
 These three viruses are antigenically distinct.
There is no cross–immunity between them.
 Of importance are the influenza A and B
viruses which are responsible for epidemics
of disease throughout the world.

CONTD..
I. Both influenza A and B viruses have two
Hemoglutinin (H) and
distinct surface antigens – the
the
Neuraminidase (N) antigens.
II. The H antigen initiates infection
following attachment of the virus to
susceptible cells. The N antigen is
responsible for the release of the
virus from the infected cell.

I. The influenza A virus is unique among the
viruses because it is frequently subject
virus to antigenic variation, both major
and minor.
I. When there is a sudden, complete or
major change, it is called a shift, and
when the antigenic change is gradual,
over a period of time, it is called a drift..

CONT...
Antigenic shift appears to result from
genetic recombination of human with
animal or avian virus, providing a
major antigenic change.
This can cause a major epidemic or
pandemic involving most or all age
groups.

CONT...
Antigenic drift involves “Point
mutation” in the gene owing to
selection pressure by immunity in the
host population.
Antigenic changes occur to a lesser
degree in the B group influenza
viruses. Influenza C appears to be
antigenically stable.

• Since the isolation of the virus A in 1933,
major antigenic changes have occurred twice
– once in 1957 (H2N2) and then again in
1968 (H3N2).
• Strains occurring between 1946 and 1957
have been called H1N1 strains. The shift in
1968 involved only the H antigen.
• In 1977, a new antigenic type appeared in
China and the USSR and the virus was
identified as A (H1N1). Within a year, it had
been isolated in countries all over the world.

• Curiously, this was an earlier virus which
has appeared after a lapse of over 20
years.
• In the past, the emergence of a new,
influenza A sub–type led to the prompt
disappearance of the previously prevalent
sub–type. In the 1977 episode, however,
this did not happen.

The prevailing A (H3N2) was not displaced.
Dual infection with both viruses were
reported.
As of now, three types of influenza viruses
– A (H1N1),A (H3N2) and B exist.
Influenza viruses of the H1N1 sub–type
have caused epidemics of the disease in
two periods of this century – from about
1946 up until 1957, and from 1977 until the
present.

STRUCTURE OF VIRION
M1 protein
HA - hemagglutinin
NA - neuraminidase
helical nucleocapsid (RNA plus
NP protein)
lipid bilayer membrane
polymerase complex

RESERVOIR OF INFECTION
It has become increasingly evident that
a major reservoir of influenza virus
exists in animals and birds.
Many influenza viruses have been
isolated from a wide variety of animals
and birds (e.g. swine, horses, dogs,
cats, domestic poultry, wild birds, etc.)

CONT...
Some of these include the major H and
N antigens related to human strains.
There is increasing evidence that the
animal reservoir provides new strains of
the influenza virus by recombination
between the influenza viruses of man,
animals and birds.

SOURCE OFINFECTION
The source of infection usually is a case
or sub–clinical case.
During epidemics, a large number of mild
and asymptomatic infections occur, which
play an important role in the spread of
infection.
The secretions of the respiratory tract are
infective.

PERIOD OF INFECTIVITY
present in
naso-pharynx
The virus is
the
a
couple of days
before and a
couple of days
after the onset of
symptoms.

HOST FACTORS

AGE AND SEX
o Influenza affects all ages and people of both
sexes. In general, the attack rate is lower
among adults. Children constitute an
important link in the transmission chain.
o The highest mortality rate during an epidemic
occurs among certain high–risk groups in the
population such as old people (generally over
65 years of age), infants under 18 months,
and persons with diabetes or chronic heart
disease, kidney and respiratory ailments.

HUMAN MOBILITY
This is an important factor in the spread of the
infection.
2-7-2020
24

IMMUNITY
Antibodies appear in about seven days
after an attack and reach a maximum
level in about two weeks. After about 8
to 12 months, antibody levels drop to
pre–infection levels.
The antibody to H neutralizes the virus
while the antibody to N modifies the
infection.

CONT...
tract after infection
Secondary antibodies develop in the
respiratory and
consist predominantly of lgG.
Antibodies must be present in sufficient
concentrations at the superficial cells (the
site of virus invasion) of the respiratory
tract.

ENVIRONMENTAL FACTORSOF INFLUENZA
Season
The seasonal incidence is striking, epidemics usually
occur in the winter months in the northern
hemisphere. In India, however, epidemics have
often occurred in summer
Overcrowding
Overcrowding enhances transmission of the
infection. The attack rates are high in closed
population groups e.g. schools, institutions, ships,
etc.

INCUBATIONPERIOD FOR INFLUENZA
The incubation period is about 18 to 72 hours.
2-7-2020
28

2-7-2020
29
PATHOGENESIS
The virus enters the respiratory tract and
causes inflammation and necrosis of the
superficial epithelium of the tracheal
and bronchial mucosa, followed by
secondary bacterial invasion.
There is no viraemia.

SIGNS AND SYMPTOMS
Symptoms begin 1-4 days after infection.
The following symptoms of the flu can vary
depending on the type of virus, a person’s age and
overall health:
• Sudden onset of chills and fever (101 – 103 F)
• Sore throat, dry cough
• Fatigue, malaise
• Terrible muscle aches, headaches
• Diarrhea
• Dizziness
Kuldeep Vyas M.Sc. CHN2-7-2020 30

Cont.....
Both viruses cause the same symptoms.
Fever lasts from one to five days,
averaging about three days in adults.
The most dreaded complication is
pneumonia, which should be suspected
if fever persists beyond four or five days,
or recurs abruptly after convalescence.

COMPLICATIONS IN CHILDREN
Studies show a link between the
development of Reye’s syndrome and the
use of aspirin for relieving fevers caused by
the influenza virus.
The disease involves the CNS and the liver
and children exhibit symptoms of
drowsiness, persistent vomiting and change
in personality.

DIFFERENCE BETWEEN COLD AND FLU
Symptoms Cold Flu
Fever Rare High
Headaches rare prominent
General aches mild severe
Fatigue mild Can last for 2-3 weeks
Extreme exhaustion absent Early and prominent
Blocked nose common sometimes
sneezing Usual sometimes
Sore throat common sometimes
Chest discomfort Mild present
Kuldeep Vyas M.Sc. CHN 332-7-2020

DIAGNOSIS OF
INFLUENZA

1. VIRUSISOLATION
 Nasopharyngeal secretions are the best
specimens for obtaining large quantities of
virus–infected cells.
 The virus can be detected by the indirect
fluorescent antibody technique.
 However, egg inoculation is required for virus
isolation and antigenic analysis.

2. PairedSera
A sero diagnosis of influenza A or B can be made by the
examination of two serum specimens from a patient. One
taken as early as possible in the acute phase of the
disease (not later than the fifth day), and another taken
about 10 to 14 days after the onset, i.e. the convalescent
stage of illness.
The titer of influenza antibodies in the human sera is so
variable that only by detecting a rise in Complement Fixing
(CF) antibodies during the course of illness, can a diagnosis
be established. Hence, the need for two specimens.
Fourfold or greater rise in titer are considered diagnostic of
infection.

In India, facilities for isolation ofthe influenza virus are availableat:-
1. Government of India Influenza Center, Pasteur
Institute, Coonoor, South India.
2. Haskine Institute, Mumbai.
3. School of Tropical Medicine, Calcutta
4. All India Institute of Medical Sciences, New
Delhi.
5. Vallabhbhai Patel Chest Institute, Delhi,
6. Armed Forces Medical College, Pune.

RAPID INFLUENZATESTS
These tests are 70% accurate for determining if
the patient has been infected with the influenza
virus and 90% accurate for determining the type
of influenza pathogen.
Examples of rapid influenza tests: Directigen
Flu A, Directigen Flu A + B, Flu OIA, Quick Vue,
and Zstat flu.
Rapid influenza tests provide results in 24 hours
and can be performed in the physician’s office.
Kuldeep Vyas M.Sc. CHN2-7-2020 38

ANTI-VIRALDRUGS
All anti-viral drugs inhibit viral replication but they act in different
ways to achieve this. Drugs that are effective against influenza A
viruses: amantadine and rimantadine.Drugs that are effective
against influenza A viruses and influenza B viruses: zanamivir and
oseltamivir.
Amantadine Rimantadine Zanamivir Oseltamivir
Type of Influenza virus infection
indicated for use
Influenza A Influenza A
InfluenzaA
InfluenzaB
InfluenzaA
InfluenzaB
Administration oral oral oral inhalation oral
Ages approved for treatmentof
flu
1 year 14 year 7 years 18 years
Ages approved for prevention
of flu
1 year 1 year not approved not approved

SYMPTOMATIC DRUGS
OTC medicines provide relief for 'flu symptoms
Symptom(s) OTC Medicine
fever, ache,
pains, sinus pressure, sore
throat
analgesics
nasal congestion, sinus
pressure
decongestants
sinus pressure, runny
nose, watery eyes, cough
antihistamines
cough cough suppressant
sore throat local anaesthetics
412-7-2020

PREVENTION
OF
INFLUENZA
2-7-2020 42

The only proven method for preventing influenza
is a yearly vaccination approximately 2 weeks
before the “flu season” begins.
Since the influenza virus is subject to genetic
mutations with the HA and NA proteins, new
vaccines that consist of different influenza
strains need to be developed each year.
Vaccine is trivalent, meaning that it provides
resistance to three strains of influenza viruses.
The vaccine consists of 2 influenza A virus
pathogens and 1 influenza B pathogen.
43
2-7-2020

• Since influenza vaccines will not control
epidemics, they are recommended only in certain
select population groups – e.g. in industry, to
reduce absenteeism and in public services, to
prevent disruption of critical public services such
as the police, fire protection, transport and
medical care.
• Moreover, certain groups e.g. the elderly and
individuals in any age group who have a known
underlying chronic or debilitating disease are
selectively immunized because of the high risk of
severe complications including death.

INFLUENZA
VACCINES

KILLED VACCINES
Most influenza vaccination programs make
use of inactivated vaccines.
Subcutaneous route. A single inoculation
(0.5ml) is usually given. However, in persons
with no previous immunological experience
two doses of the vaccine, separated by an
interval of three to four weeks are considered
necessary to induce satisfactory antibody
levels

• The protective value of the vaccine varies between
70 to 90 per cent and immunity lasts for only three
to six months. Re–vaccination on an annual basis
is recommended.
• The killed vaccine can produce fever, local
inflammation at the site of injection, and very
rarely Guillain–Barre syndrome (an ascending
paralysis).
• Since the vaccine strains are grown in eggs,
persons allergic to eggs may develop the
symptoms and signs of hypersensitivity.

LIVE ATTENUATEDVACCINES
Live attenuated vaccines based on
temperature–sensitive (ts) mutants have been
extensively used in the USSR. They may be
administered as “Nose drops” into the
respiratory tract.
They stimulate local as well as systemic
immunity. The frequent antigenic mutations
of the influenza virus present difficulties in
the production of effective vaccines,
particularly live vaccines.
2-7-2020
48

NEWER VACCINES
Split–virus Vaccine
It is also known as the sub–virion vaccine. It
is a highly purified vaccine, producing
fewer side effects than the “Whole virus”
vaccine. Due to its lower antigenicity, it
requires several injections instead of a
single one. It is recommended for children.

NEURAMINIDASE–SPECIFIC VACCINE
It is a sub–unit vaccine containing only
the N antigen, which induces antibodies
only to the neuraminidase antigen of the
prevailing influenza virus.
The antibody to neuraminidase reduces
both the amount of virus replicating in
the respiratory tract and the ability to
transmit virus to contacts.

RECOMBINANT VACCINE
By recombinant
techniques, the
desirable antigenic
properties of a virulent
strain can be
transferred to another
strain known to be of
low virulence. Efforts
to improve the
influenza vaccine have
been continuing.

Influenza (Common Cold)

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Influenza (Common Cold)

Similar to Influenza (Common Cold) (20)

More from KULDEEP VYAS

More from KULDEEP VYAS (20)

Recently uploaded

Recently uploaded (20)

Influenza (Common Cold)